loading
Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
 - - 0.10 -
Operating Expenses
33.81
 - 42.90 50.03 46.80
Operating Income/Loss
-33.81
 - -42.90 -49.93 -46.80
Nonoperating Income/Loss
-1.444
 - -0.41 2.063 2.933
Income/Loss From Continuing Operations Before Tax
23.04%
-35.26
 -28.65 -43.31 -47.87 -43.86
Income Tax Expense/Benefit
-
 - - - -
Income/Loss From Continuing Operations After Tax
23.04%
-35.26
 -28.65 -43.31 -47.87 -43.86
Net Income/Loss
23.04%
-35.26
 -28.65 -43.31 -47.87 -43.86
Preferred Stock Dividends And Other Adjustments
-
 - - - -
Attributable To Noncontrolling Interest
-
 - - - -
Basic Average Shares
15.48
 - 15.47 0.224 15.47
Diluted Average Shares
15.48
 - 15.47 0.163 15.47
Basic Earnings Per Share
-2.28
 - -2.80 -5.03 -2.84
Diluted Earnings Per Share
-2.28
 - -2.80 -4.47 -2.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
 - - - -

Simile a INBX

biotechnology RPRX
$45.65
price down icon 0.48%
biotechnology ROIV
$28.06
price down icon 1.72%
biotechnology MRNA
$52.56
price down icon 1.55%
biotechnology BNTX
$91.19
price up icon 1.21%
biotechnology INSM
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):